FDA Clearance Tracker · P230021-S002
Duo Venous Stent System
Last checked: Nov 20, 2026Latest source record: Nov 18, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 18, 2025
Approved
Time to decision
110 days
Received Jul 31, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P230021-S002
- Device name
- Duo Venous Stent System
- Applicant location
- Plymouth, MN
- Received
- Jul 31, 2025
- Decided
- Nov 18, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P230021
Device type
- Device type
- Stent, iliac vein (QAN)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a design ownership and legal manufacturer located at Philips Image Guided Therapy Corporation (Philips), 5905 Nathan Lane North, Plymouth, MN 55442 and 9965 Federal Drive, Colorado Springs, CO 80921 USA
Source documents
Other decisions for Philips Image Guided Therapy Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- IntraSight Plus510(k)
K253714 · Decided Feb 24, 2026 · 92 days after receipt
Device type: System, Imaging, Pulsed Echo, Ultrasonic (IYO) · Radiology & Imaging
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.